We would love to hear your thoughts about our site and services, please take our survey here.
Well said notrex, absolute shambles. AS is like a Labour Government, good at spending other people's money until it runs out. Too old now to stay in and wait for eventual commercialisation. Even that's not guaranteed when you look at OBD. Scientists trying to be businessman eh!
You can fool some of the people all of the time. You can fool all of the people some of the time. However, you can't fool all of the people all of the time. Eventually the penny drops. Gutted to have been taken for a ride by yet another Aim snake oil salesman. Lesson learned but a painful one. Genuinely hope all you LTHs get a return eventually.
So Wyn was correct in his prediction. Just a cheerleaders rampfest after all! Keep hanging on every word of Watching 2 guys.
The fact remains watching that those who took your advice and bought in when you said it wouldn't go below £1 now have a 20% paper loss (nearly). So who's the clown? 😂
Sentiment and fear of a cash raise and the dilution it brings - simples Watching 2. Oh and it did break £1 when you said it wouldn't and anyone who was convinced by you at the time now has a 15% paper loss.
No point at all at this stage Timster because the market certainly isn't is it?
You did say that it wouldn't go below £1 though didn't you Watching 2? This is AIM guys and girls. Pound cost average or wait for a new trading range. This looks like it's a bargain but it did at 110p too. The ultimate reward could be huge here as we all know but many will bale out at £2.
My hope is that the therapeutics division will be sold off to BP so that the platform can be fast tracked. AVCT could then concentrate on developing a first class diagnostics company and the infrastructure is being developed for this. I have a mate having a biopsy on his pancreas today. I'd rather see him get targeted chemotherapy than make money any day. The quicker all these new prodrugs can be brought into use the better.
Can't see the CEO of "the next Roche" wanting to do this but if he's getting sound business advice it might be the best option. What we need is a mega rich investor who wants to help him fulfill his ambition.
Timster, less is more is a good adage. Try it sometime and get a life away from this board
Ive been an anxious holder since I first bought in at 18p donkey. I wonder if Heights made that intention clear to AS during negotiations or perhaps he thought he would be able to pay them in cash rather than shares?
I understand your point JT, thank you. However the market trades on confidence and Heights selling their share allocation, when presumably they, more than most, are in the know can hardly reassure anybody invested. The lack of institutional Investors, particularly after the Science Day, means that there are still concerns about the ability of the company to make a profit until some time into the future. Personally, I think the value of the IP is worth far more than the current market capitalisation so, if you have a medium to long term investment horizon, it's a pretty safe bet at this level. Expect volatility and cheap can always get cheaper is the AIM reality. Quite a lot of people on here trade a proportion of their holding in order to mitigate the paper losses when the SP is temporarily depressed, as I believe it to be now. I don't think it's right for anyone to denegrate such individuals. I shall certainly sell a portion of my holding if it spikes higher and if I miss out on a portion of the massive payday for a BP buyout that some widely predict, so be it.
JT, I admire your deep scientific knowledge and your willingness to share it on this board. It's one of the reasons I am hanging on even though, like most LTHs I am currently suffering a paper loss. Everyone has a timescale for investment in any company and one's perspective differs depending on so many factors including wealth, age, previous experience of AIM companies and scientists trying to run them etc. Everyone is entitled to an opinion and noone really knows where we are with the future financing. All we have is a vague assurance from a scientist trying to head up "the next Roche" that shareholders shouldn't have concerns. You only have to look at the recent SP performance of a company like OBD, that now has products to commercialise, to see what can happen if there's a lack of expertise in how to make a profit. The fact is that the market is unconvinced and that's why we're where we are.
Yep Timmy and neither do you!
Bottom in at a £1 or a dead cat bounce? My guess is the former.
Well it's not under a quid yet so you're still right!
We shall see Watching. I'd much rather see the RNS personally.
It's no surprise to me following my recent experience of the urology department in my local NHS hospital. They had no knowledge of the PSE diagnostic test for prostate cancer developed by OBD and now available for use (privately only at the moment) in the UK and the USA, nor had the urologist I saw (who had a string of letters after his name) heard of the Echo laser treatment technique for reducing the pressure on the urethra caused by an enlarged prostate. He didn't believe me until he googled it on his phone in my presence! Having said this, a good mate is now in remission from bladder cancer following treatment at the same hospital. He's a lucky man as he left it late to present with the symptoms. Guys, get the message; if things don't seem right get yourself tested and get it picked up early. You owe it to your families
If you have faith in the IP, and can afford to wait, the current SP looks a bargain. From experience of AIM, it could become even more of a bargain as concerns over funding the programmes grow. If I was a younger person, with funds available I would be adding cautiously at this stage and using pound cost averaging.
Hi Donkey,
I personally think that my biopsy was unnecessary but I had different opinions from two urologists following an MRI scan and I went with the view of the NHS guy as the procedure was offered under the NHS. The existence of the PSE test (then) would have avoided what is an invasive process with a corresponding risk of infection. My post procedure experience was not as severe as your friend's but it did result in an overnight stay in hospital for observation. I imagine that adoption by the NHS, as part of a screening program, would substantially lower the cost of the PSE test but I doubt it will happen in my lifetime.